Wednesday, February 10, 2010, 5:20pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Cubist Pharmaceuticals Inc. (CBST)

At 5:00AM SGT: 20.58 USD   0.00 (0.00%)  
 MORE ON CBST 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Cubist Pharmaceuticals, Inc. (NasdaqNM:CBST) Delayed quote dataEdit
Last Trade:20.58 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:20.58
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:21.83
Day's Range:N/A - N/A
52wk Range:13.81 - 22.39
Volume:0
Avg Vol (3m):623,421
Market Cap:1.19B
P/E (ttm):7.53
EPS (ttm):2.73
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add CBST to Portfolio   Download Data

 HEADLINES 
•Four Stock Ideas for a Muddled Market
at Seeking Alpha (Tue, Feb 2)
•5-Star Stocks on the Upswing
at Motley Fool (Sat, Jan 30)
•Today's 5-Star Movers
at Motley Fool (Thu, Jan 28)
•New Star Analyst Rankings for Cubist Pharmaceuticals, Inc.
StarMine (Sun, Jan 24)
•Cubist Misses Estimate
Zacks.com (Fri, Jan 22)
•Cubist Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Fri, Jan 22)
•Cubist 4Q profit tumbles without tax benefit
AP (Fri, Jan 22)
•Cubist Pharmaceuticals Fourth Quarter 2009 Earnings Call scheduled for 5:00 pm ET today
Vcall (Fri, Jan 22)
•CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Fri, Jan 22)
•Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million
Business Wire (Fri, Jan 22)
•Q4 2009 Cubist Pharmaceuticals, Inc. Earnings Release - Time Not Supplied
CCBN (Thu, Jan 21)
•A Closer Look at Cubist Pharma
at Seeking Alpha (Fri, Jan 15)
•Correction: Cubist Revenue Outlook
AP (Thu, Jan 14)
More Headlines for CBST...
 ANALYST 
EPS Est (next year) (Dec-09) :1.23
EPS Est (in 2 years) (Dec-10) :1.53
Avg Rec (current)*:2.7
PEG Ratio:1.07
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices